Manufacturer record
CSD Lifesciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by CSD Lifesciences (Himachal Pradesh) were declared Not of Standard Quality between December 2024 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to CSD Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sucrapolis-O Suspension | CSDL24368Mfg 2024-10 · Exp 2026-09 | sample does not conform to label claim with respect to the content of OxetacaineLabelling | DTL ChennaiState lab | Apr 2025 |
| Trubery LS | Z-23388Mfg 2023-09 · Exp 2025-08 | Sample does not conform to Label with respect to the content of Levosalbutamol in Levosalbutamol sulphate.Labelling | DTL ChennaiState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.